ImmuLogic Pharmaceutical Corp. (A): March 1991

ImmuLogic Pharmaceutical Corp. (A): March 1991: "

ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems of valuation are highlighted. The challenges posed by "windows" for public offerings are considered.

Learning Objective: To explore implications of going public; to examine he motivation of the various actors in the going public decision; and to understand the problem of valuation.

"